The Schedule of Pharmaceutical Benefits was updated on 1 June 2023. New, Amended and Deleted items can be found on the Summary of Changes page.

The following updates have also been made to the PBS Website on the dates specified.

• Ex-manufacturer price - 1 June 2023
• Formulary Allocations - 1 June 2023
• Drugs subject to Price Disclosure - 1 June 2023
• Medicine Status Website - 1 June 2023
• Opioid Dependence Treatment Program - 26 May 2023
• Health Technology Assessment Policy and Methods Review Consultation and Updates from the Health Technology Assessment Policy and Methods Review Reference Committee - 26 May 2023
• PBAC Public Summary Documents - 24 May 2023
• PBS and RPBS Section 85 Date of Supply Data - 16 May 2023
• Outcome in relation to fluticasone propionate – PBAC May 2023 Intracycle meeting - 12 May 2023
• Public Consultation: Draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the PBS and designated vaccines on the NIP - 12 May 2023
• May 2023 Updates from the Health Technology Assessment Policy and Methods Review Reference Committee - 11 May 2023
• Reforming Opioid Dependence Treatment Access - 10 May 2023
• Recommendations made out-of-session by the PBAC between March 2023 and July 2023 meetings - 10 May 2023
• Publication of Notification Form for likely or actual breach of minimum stockholding requirements - 8 May 2023
• Updated Agenda for the July 2023 PBAC meeting - 5 May 2023
• PBS subsidy arrangements for cefaclor SSSI - 2 May 2023